MMJ Recs

MAY 10, 2022

For people who need medical marijuana in the state of Utah, gaining access isn’t always a straightforward process. If you fall under any of the above categories, you can apply to gain access to medical marijuana in Utah. If one dispensary is holding the event, that is where each patient will be directed.

Patients 52

Patients Dispensary Events Chronic Pain 52

Cannabis Law Report

SEPTEMBER 24, 2019

T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. The medication, developed by GW Pharmaceuticals, will be used in combination with another epilepsy medication called clobazam. What about other medical cannabis products? PDF Version.

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

Veriheal

FEBRUARY 28, 2021

It helps to showcase the 103 countries holding events on this day as well as the thousands of events hosted online worldwide. This year, COVID-19 has dramatically impacted the way events are hosted. Instead of having physical locations, many events have opted to go digital being held online.

Chronic Pain 52

Chronic Pain Events Therapy Treatment 52

MMJ Recs

APRIL 30, 2022

Getting access to medical marijuana in the state of Virginia requires patients to complete a few different steps in the application process. In some cases, there are events known as patient drives that can make the process even easier for qualifying individuals to get their recommendation and access medical marijuana.

Patients 52

Patients Dispensary Chronic Pain Access 52

SpeedWeed

APRIL 2, 2021

The legacy of Charlotte Figi, the young Colorado girl whose struggle with epilepsy made CBD known worldwide, will be remembered next week with a benefit concert taking place in her honor. She had a rare form of epilepsy known as Dravet syndrome that caused dozens or even hundreds of seizures per day. A Benefit For Realm Of Caring.

Events 52

Events Epilepsy Cannabinoids Treatment 52

MMJ Recs

MAY 5, 2022

People in Louisiana looking to gain access to medical marijuana have to follow a few procedural steps to get approved and buy from a licensed dispensary. In the state of Louisiana, there are several approved conditions for people looking to gain access to cannabis products. How to take advantage of Louisiana patient drive events.

Patients 52

Patients Dispensary Conditions Access 52

Cannabis Law Report

DECEMBER 7, 2021

While cannabidiol was associated with a reduction in reported seizure events (RR?=?0.59, A qualitative assessment suggests that medical cannabinoids might be associated with adverse mental events. Adverse mental events were reported as well, however, more research should be performed to assess well this outcome. 1.69, 95% CI [1.20–2.36])

Safety 52

Safety Cannabinoids Events Data 52

Sensi Seeds

JANUARY 7, 2019

As a long-time cannabis activist, entrepreneur and educator in a career spanning 40 years, today DeAngelo is the CEO of Harborside Health Center in Oakland, California, and a regular speaker at international industry events.

Education 94

Education Dispensary Media Cannabis 94

The Cannigma

APRIL 12, 2023

Medical cannabis in Chile Chile legalized medical cannabis in 2015, allowing patients to access cannabis-based medicines with a prescription from a doctor. Chile hosts several annual cannabis-related events, including the Expoweed fair , which attracts thousands of attendees each year.

Law 52

Law Decriminalization Recreational Epilepsy 52

MMJ Recs

APRIL 15, 2022

Having a valid Missouri MMJ card guarantees you legal and safe access to medical cannabis products to help manage or treat your symptoms. MMJ patient drives are a vital initiative that improves access to MMJ cards in Missouri by catering to those who may otherwise find it difficult to travel to urban centers for their consultation.

Patients 52

Patients Chronic Pain Conditions Dispensary 52

Cannabis Law Report

MARCH 2, 2020

The UK government has eased import restrictions on medicinal cannabis, but has admitted it needs to do much more to improve access for patients. In November last year, the National Institute for Health and Care Excellence (NICE) recommended 2 cannabis-based medicinal products for patients with multiple sclerosis and hard-to-treat epilepsies.

Medicine 45

Medicine Research and Development Clinical Trials Patients 45

MMJ Recs

JUNE 23, 2024

Qualifying Conditions for Medical Marijuana in Pennsylvania Pennsylvania’s Medical Marijuana Program provides legal access to medical cannabis for patients diagnosed with a range of qualifying conditions. Epilepsy: Epilepsy is a neurological disorder characterized by recurrent seizures, which can vary in severity and frequency.

Conditions 52

Conditions Marijuana Patients Chronic Pain 52

MMJ Recs

DECEMBER 20, 2023

To access medical marijuana, patients must obtain a written certification from a registered healthcare practitioner confirming their eligibility. These include, but are not limited to, cancer, glaucoma, HIV/AIDS, Parkinson’s disease, and epilepsy. Common discounts include those for veterans, seniors, and low-income individuals.

Dispensary 52

Dispensary Marijuana Strains Patients 52

CannaTech

JUNE 30, 2019

Changes to Israeli medical cannabis regulation by the Ministry of Health’s Medical Cannabis Association, locally known as Yakar, have left vulnerable patients with reduced access and increasing cots. Although changes were intended to reduce barriers to patient access, this has not been the case. Severe epilepsy in minors.

Patients 40

Patients Oil Epilepsy Strains 40

SpeedWeed

MAY 5, 2021

Last week was eventful for cannabis reform in Texas, as the House of Representatives approved three legislative proposals, which would expand the state’s medical cannabis program, reduce penalties for concentrates and decriminalize possession. 1535 would also raise the THC limit in medical cannabis from 0.5%

Programs 52

Programs Chronic Pain Concentrates THC 52

SpeedWeed

MAY 4, 2021

Last week was eventful for cannabis reform in Texas, as the House of Representatives approved three legislative proposals, which would expand the state’s medical cannabis program, reduce penalties for concentrates and decriminalize possession. 1535 would also raise the THC limit in medical cannabis from 0.5%

Programs 52

Programs Chronic Pain Concentrates THC 52

CannaTech

FEBRUARY 3, 2020

CannaTech is an international event experience that unites cannabis professionals with breakout industry leaders for an unparalleled opportunity to learn, connect and define what’s next for the global cannabis industry. CBD-derived epilepsy drug Epidiolex is currently available in Swiss pharmacies as a prescription drug.

Events 52

Events Hemp CBD Medicine 52

Veriheal

OCTOBER 5, 2020

This bill also allows for dispensaries to “provide, disseminate, and publish educational and scientific material related to medical cannabis and its approved products and sponsor events about medical cannabis”. . Summary of Hawaiian Cannabis Regulations. Act 228 allows for the growth of cannabis for medical purposes. .

Edibles 52

Edibles Legalization Decriminalization Consumption 52

MMJ Recs

MARCH 25, 2022

MMJ patient drives can help more people to access the medical marijuana they need. Patient drives are like pop-up day events, during which many people can avail of quick and easy appointments for MMJ cards if they have a qualifying condition. What is a NY patient drive? So, what is a New York patient drive ?

Patients 52

Patients Conditions Chronic Pain Dispensary 52

WeedAdvisor

MARCH 29, 2019

While CBD was already well-known to many medical users, those with only recreational access quickly fell into the hype. The most extensive research involved patients with severe – often untreatable – epilepsy. Following successful trials for children with LGS and Dravet Syndrome, the U.S.

Oil 40

Oil CBD Research and Development Epilepsy 40

Puff Puff Post

MARCH 2, 2020

tonnes approved, 50% are for Colombian domestic use and 50% are allowed for export purposes. · Export quotas allow for the manufacture of whole plant extract for international purposes to countries such as Peru, Uruguay, and Brazil, thereby accessing to a medical cannabis market of $1.4 . · Of the 9.3 United States Disclaimer.

Extraction 52

Extraction THC Chronic Pain Cultivation 52

Cannabis Law Report

JANUARY 26, 2022

MAPS Public Benefit Corporation will coordinate trial design with Medicines and Healthcare products Regulatory Agency to create a road map for early patient access in the UK. Our promising Phase 3 results lead us to apply for the Innovation Passport. Corine de Boer, M.D., Chief Medical Officer at MAPS PBC.

Therapy 52

Therapy Clinical Trials Research and Development Treatment 52

Cannabis Law Report

OCTOBER 12, 2019

The scheme allows patients and doctors to access a legal domestic source of cannabis for medicinal use. The introduction of new legislation in Queensland (revoking the Public Health (Medicinal Cannabis) Act 2016 (Qld)) to simplify the process for patients and doctors to access medicinal cannabis. What’s next?

Medicine 40

Medicine Research and Development Cultivation Legislation 40

Cannabis Law Report

JANUARY 13, 2020

commercial and government payors to ensure that appropriate patients have access to Epidiolex with as few restrictions as possible. GW undertakes no obligation to update or revise the information contained in this press release, whether as a result of new information, future events or circumstances or otherwise. Work with U.S.

Pharmaceutical 51

Pharmaceutical Clinical Trials Research and Development Programs 51

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. Patients can legally access medicinal cannabis through a doctor, via the TGA’s Authorised Prescribers and Special Access schemes.

Research and Development 52

Research and Development Medicine Access Media 52

MMJ Recs

OCTOBER 2, 2023

California has been a trailblazer in the realm of medical marijuana, offering patients access to a variety of treatment options. Medical marijuana requires a doctor’s recommendation and provides certain advantages, including lower taxes and access to a broader range of products.

Dispensary 52

Dispensary Patients Environment Conditions 52

Cannabis Law Report

OCTOBER 1, 2021

The presentation can be accessed by registering (at no cost) for the Investor Forum at www.channelchek.com ; the investor portal created by Noble. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Eastern time. Channelchek (.com)

Research and Development 40

Research and Development Pharmaceutical Clinical Trials Chronic Pain 40

MMJ Recs

MARCH 2, 2024

In Ohio, accessing medical marijuana involves more than just obtaining a prescription; it requires navigating a complex landscape of dispensaries, regulations, and patient expectations. By utilizing the Ohio Medical Marijuana Dispensaries Map, patients can confidently explore their options and access quality medical cannabis products.

Dispensary 52

Dispensary Patients Marijuana Education 52

Cannabis Law Report

SEPTEMBER 23, 2019

Surveying marijuana use is essential to gauge public health implications of increased access to marijuana, cannabinoid, and cannabis products. People who are incarcerated have significantly higher rates of disease than those who are not, and are less likely to have access to adequate medical care. Accessed August 20, 2019.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

Puff Puff Post

NOVEMBER 30, 2018

They want to push for access to CBD oil to treat sick animals. Our pets also develop chronic diseases and illnesses like cancer and epilepsy. Of note, if his anxiety and behavioral problems are related to an event (fireworks or traveling), given him CBD oil at least half an hour before the event.

Pets 76

Pets Oil CBD Research and Development 76

Puff Puff Post

MARCH 2, 2020

tonnes approved, 50% are for Colombian domestic use and 50% are allowed for export purposes. · Export quotas allow for the manufacture of whole plant extract for international purposes to countries such as Peru, Uruguay, and Brazil, thereby accessing to a medical cannabis market of $1.4 . · Of the 9.3 United States Disclaimer.

Extraction 40

Extraction THC Chronic Pain Cultivation 40

Cannabis Law Report

DECEMBER 1, 2021

Because it can cross the blood-brain barrier and gain access to the central nervous system (CNS), MYMD-1 is also positioned to be a possible treatment for brain-related disorders. The Company believes that Supera-CBD is currently on a path toward human clinical trials as a therapy for epilepsy, followed by chronic pain. Robert Schatz.

Pharmaceutical 40

Pharmaceutical Clinical Trials Chronic Pain Therapy 40

Cannabis Law Report

JUNE 1, 2021

Steve Barbera to Vice President, Market Access. Prior to joining Sesen Bio, Mr. Barbera served as the Vice President of Market Access at UroGen Pharma and played a critical role in the launch of the company’s first commercial product, Jelmyto ®. Julie Hoff to Vice President, Human Resources.

Research and Development 51

Research and Development Treatment Pharmaceutical Patients 51

Cannabis Law Report

JANUARY 20, 2022

Eleusis pioneers the development of psychedelic drug candidates in the life sciences space, with the goal of transforming psychedelics into broadly accessible medicines. Medicines and Healthcare products Regulatory Agency’s Innovative Licensing and Access Pathway (“ILAP”), offering the potential to accelerate time to market.

Therapy 40

Therapy Research and Development Business Access 40

Cannabis Law Report

NOVEMBER 23, 2021

Because it can cross the blood-brain barrier and gain access to the central nervous system (CNS), MYMD-1 is also positioned to be a possible treatment for brain-related disorders. The Company’s second drug platform, Supera-CBD , is being developed to treat chronic pain, addiction and epilepsy. MyMD Contact: Robert Schatz.

Pharmaceutical 40

Pharmaceutical Clinical Trials Therapy Chronic Pain 40

The Cannigma

DECEMBER 22, 2021

The Cannabis Enigma is a co-production of The Cannigma and Americans for Safe Access. We’ve got our regular segment with Americans for Safe Access. We have autism and epilepsy. CP: With Debbie Churgai, Executive Director of Americans for Safe Access. Music by Desca. I won’t do too many spoilers here.

Research and Development 79

Research and Development Oil Cannabis Clinical Trials 79

Cannabis Law Report

JANUARY 5, 2022

Because it can cross the blood-brain barrier and gain access to the central nervous system (CNS), MYMD-1 is also positioned to be a possible treatment for brain-related neurodegenerative and neuroinflammatory disorders. The Company’s second drug platform, Supera-CBD , is being developed to treat chronic pain, addiction and epilepsy.

Pharmaceutical 40

Pharmaceutical Clinical Trials Therapy Treatment 40